ILLUMINA INC·4

Dec 13, 6:21 PM ET

Hampton Malcolm Garret 4

4 · ILLUMINA INC · Filed Dec 13, 2018

Insider Transaction Report

Form 4
Period: 2018-12-11
Hampton Malcolm Garret
EVP Clinical Genomics Group
Transactions
  • Award

    Common Stock

    2018-12-11+1,9018,101 total
  • Award

    Performance Shares

    2018-12-11+5,7015,701 total
    Exp: 2022-01-02Common Stock (5,701 underlying)
Footnotes (2)
  • [F1]Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2019, November 5, 2020, November 5, 2021 and November 5, 2022, subject to awardee's continuing status as a service provider on such dates.
  • [F2]Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 2, 2022. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 2, 2022, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT